Ketorolac for acute ED pain: Findings from 40 RCTs :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Ketorolac offers effective nonopioid analgesia for acute pain in emergency department

Acute pain Acute pain
Acute pain Acute pain

What's new?

Ketorolac provides analgesia comparable to opioids across multiple acute pain conditions in adults presenting to the emergency department.

A systematic review and meta-analysis of 40 randomized controlled trials (RCTs) found that ketorolac provides similar pain relief to opioids and several other analgesics, but does not demonstrate a consistent advantage over other nonsteroidal anti-inflammatory drugs (NSAIDs).

The evidence at a glance

Researchers reviewed 40 RCTs involving adults with acute pain treated in emergency departments (EDs). The studies covered:

  • Acute renal colic: 14 RCTs; 1,776 patients
  • Headache: 10 RCTs; 942 patients
  • Nontraumatic musculoskeletal pain: 6 RCTs; 683 patients
  • Traumatic musculoskeletal pain: 3 RCTs; 318 patients
  • Biliary colic: 3 RCTs; 400 patients

The PubMed search included English-language studies published through February 2023.

How did ketorolac perform?

  • Renal colic: Ketorolac generally produced pain relief comparable to morphine, ketamine, diclofenac, and meperidine. In one trial, 800 mg intravenous ibuprofen reduced pain more effectively than 30 mg intravenous ketorolac. Different ketorolac doses—10, 20, and 30 mg intravenously—showed similar analgesic effects.
  • Headache: Ketorolac illustrated broadly comparable efficacy to metoclopramide and chlorpromazine. However, some alternatives performed better in specific settings. After removal of two outliers, pooled analysis showed a small difference favoring comparator treatments (coefficient, 0.67).
  • Musculoskeletal pain: Ketorolac offered pain alleviation comparable to ibuprofen, diclofenac, meperidine, acetaminophen/codeine, and intravenous lidocaine.
  • Traumatic pain: Intravenous ketorolac illustrated analgesia comparable to morphine in patients with limb trauma and long-bone fractures. Ketorolac was also comparable to 800 mg oral ibuprofen.
  • Biliary colic: Ketorolac elicited pain relief comparable to butorphanol and meperidine. Meperidine was linked with more nausea and dizziness in one study.

Ketorolac vs. other NSAIDs

Only 7 studies directly compared ketorolac with other NSAIDs, primarily ibuprofen or diclofenac. None illustrated clear superiority of ketorolac. The authors therefore emphasize an important evidence gap: direct, adequately powered comparisons between ketorolac and commonly used NSAIDs remain limited.

What does this mean for emergency care?

The findings position ketorolac as a nonopioid analgesic option for acute pain in adults in the ED, with analgesic potency broadly comparable to opioids across several pain ailments. However, the evidence does not show that ketorolac is consistently more effective than other NSAIDs. Further head-to-head trials are needed to clarify its comparative efficiency.

Source:

Clinical and Experimental Emergency Medicine

Article:

Ketorolac analgesia in the emergency department in adults: a systematic review and meta-analysis

Authors:

Antimo Tessitore et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: